ACCD - Accolade Inc Stock Price, Fair Value and News

4.07USD+0.22 (+5.71%)Market Closed

Market Summary

USD4.07+0.22

Market Closed

5.71%

ACCD Alerts

JPMORGAN CHASE & CO reported owning 3.6% of ACCD [2024-07-03]

Losses in recent quarter

ACCD Stock Price

View Fullscreen

ACCD RSI Chart

ACCD Valuation

Market Cap

325.6M

Price/Earnings (Trailing)

-3.66

Price/Sales (Trailing)

0.75

EV/EBITDA

-3.25

Price/Free Cashflow

-37.12

ACCD Price/Sales (Trailing)

ACCD Profitability

EBT Margin

-20.28%

Return on Equity

-20.44%

Return on Assets

-11.6%

Free Cashflow Yield

-2.69%

ACCD Fundamentals

ACCD Revenue

Revenue (TTM)

431.5M

Rev. Growth (Yr)

18.49%

Rev. Growth (Qtr)

-11.51%

ACCD Earnings

Earnings (TTM)

-89.0M

Earnings Growth (Yr)

28.16%

Earnings Growth (Qtr)

-267.55%

Breaking Down ACCD Revenue

Last 7 days

18.0%

Last 30 days

-33.6%

Last 90 days

-48.4%

Trailing 12 Months

-71.2%

How does ACCD drawdown profile look like?

ACCD Financial Health

Current Ratio

2.8

ACCD Investor Care

Shares Dilution (1Y)

5.79%

Diluted EPS (TTM)

-1.24

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	414.3M	431.5M	0	0
2023	363.1M	370.8M	380.1M	388.5M
2022	310.0M	336.0M	350.4M	357.9M
2021	170.4M	194.0M	230.5M	275.5M
2020	132.5M	139.6M	146.8M	155.6M
2019	94.8M	104.2M	113.7M	123.1M

Get all data in R, Python etc through our Historical Stock Data APIs

About Accolade Inc

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. It also provides medical opinion and decision support services; and technology and administrative services to the medical practice PCs providing virtual primary care services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

CEO	Mr. Rajeev Singh
WEBSITE	accolade.com
INDUSTRY	Healthcare Plans
EMPLOYEES	2370

Accolade Inc Frequently Asked Questions

What is the ticker symbol for Accolade Inc? What does ACCD stand for in stocks?

ACCD is the stock ticker symbol of Accolade Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Accolade Inc (ACCD)?

As of Fri Jul 26 2024, market cap of Accolade Inc is 325.63 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ACCD stock?

You can check ACCD's fair value in chart for subscribers.

Is Accolade Inc a good stock to buy?

The fair value guage provides a quick view whether ACCD is over valued or under valued. Whether Accolade Inc is cheap or expensive depends on the assumptions which impact Accolade Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ACCD.

What is Accolade Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, ACCD's PE ratio (Price to Earnings) is -3.66 and Price to Sales (PS) ratio is 0.75. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ACCD PE ratio will change depending on the future growth rate expectations of investors.